Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2026-05-29 Interim / Quarterly Rep…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Śródroczne SSF Grupy Kapitałowej Bioton S.A.Q12026
Interim / Quarterly Report Classification · 93% confidence The document is a condensed interim (quarterly) consolidated and individual financial report for the period ended March 31, 2026, including income statement, comprehensive income, balance sheet, cash flows, changes in equity, and explanatory notes. It contains substantive financial data for a period shorter than a full fiscal year, matching the definition of an Interim / Quarterly Report. Q1 2026
2026-05-29 Polish
Raport kwartalny Q1 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “Skonsolidowany Raport kwartalny Grupy BIOTON S.A. za I kwartał 2026 r.” and contains consolidated and individual condensed financial statements for the first quarter of 2026, narrative discussion of results, segment breakdowns, balance sheet, income statement, cash flow details, management commentary, and regulatory disclosures under the Polish Financial Minister’s quarterly reporting regulation. It is a comprehensive quarterly report (interim financial statements) rather than an announcement or mere summary. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-29 Polish
Informacja o stwierdzeniu wykonalności zagranicznego wyroku sądu polubownego - Content (PL)
Legal Proceedings Report Classification · 86% confidence The document is a company announcement detailing the outcome of a legal arbitration enforcement proceeding before the Warsaw Court of Appeal, including court orders, arbitration award enforcement, and discussion of next legal steps. It clearly pertains to an update on significant legal proceedings rather than financial results, governance materials, or a report publication notice. This matches the Legal Proceedings Report category.
2026-05-26 Polish
Raport z oceny sprawozdanie o wynagrodzeniach
Audit Report / Information Classification · 95% confidence The document is an independent auditor’s assurance report (biegłego rewidenta) on the completeness of the statutory remuneration report prepared for Bioton S.A. It sets out the auditor’s scope, responsibilities, applicable standards, procedures performed, and opinion. It is a standalone audit report, not a full annual or interim report, not merely a publication announcement, and not a corporate officer certification. This matches the definition of Audit Report / Information (Code: AR). FY 2025
2026-05-25 Polish
Sprawozdanie Rady Nadzorczej o wynagrodzeniech
Remuneration Information Classification · 85% confidence The document is the Supervisory Board’s annual report on the remuneration of Management Board and Supervisory Board members for the financial year 2025. It provides a detailed breakdown of fixed and variable compensation, benefits, and remuneration policy in accordance with legal requirements. This corresponds to a Remuneration Information filing. Therefore, the appropriate classification is Remuneration Information (Code: DEF 14A).
2026-05-25 Polish
Sprawozdanie Rady Nadzorczej za rok 2025
Governance Information Classification · 85% confidence The document is the standalone Report of the Supervisory Board of BIOTON S.A. for the financial year 2025, containing details on board composition and changes, audit committee structure, meeting activity, governance assessments, and recommendations to the General Meeting. It is not the company’s full Annual Report or financial statements, nor an earnings release or a proxy solicitation per se, but rather a statutory corporate governance report prepared by the Supervisory Board setting out its activities, assessments, and adherence to governance rules. This aligns with our “Governance Information” category (CGR).
2026-05-25 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.